The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Osteofos D3 1200mg/800 I.U. powder for oral suspension

Menarini International Operations Luxembourg S.A.PA0865/007/001

Main Information

Trade NameOsteofos D3 1200mg/800 I.U. powder for oral suspension
Active SubstancesCalcium phosphate
Dosage FormPowder for oral suspension
Licence HolderMenarini International Operations Luxembourg S.A.
Licence NumberPA0865/007/001

Group Information

ATC CodeA12AX Calcium, combinations with vitamin D and/or other drugs


License statusWithdrawn
Withdrawn Date21/08/2023
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back